BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katsumata Y, Suzuki T, Kuwana M, Hattori Y, Akizuki S, Sugiura H, Matsuoka Y. Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis. Arthritis Rheum 2003;48:1647-51. [PMID: 12794833 DOI: 10.1002/art.10965] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Carter C. Alterations in Blood Components. Comprehensive Toxicology. Elsevier; 2018. pp. 249-93. [DOI: 10.1016/b978-0-12-801238-3.64251-4] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Roeser A, Moulis G, Ebbo M, Terriou L, Poullot E, Lioger B, Chilles M, Labussière-Wallet H, Mausservey C, Pha M, Puyade M, Cheze S, Limal N, Michel M, Godeau B, Mahévas M. Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia. Br J Haematol 2022. [PMID: 35538740 DOI: 10.1111/bjh.18235] [Reference Citation Analysis]
3 Her MY, Kim TH, Chang HK, Lee WS, Yoo DH. Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease. Rheumatol Int 2007;27:295-8. [PMID: 16957888 DOI: 10.1007/s00296-006-0202-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
4 Ninos JM, Jefferies LC, Cogle CR, Kerr WG. The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J Transl Med 2006;4:9. [PMID: 16480521 DOI: 10.1186/1479-5876-4-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
5 Roy AM, Konda M, Sidarous GK, Atwal D, Schichman SA, Kunthur A. Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case Report. Perm J 2020;24:1-3. [PMID: 33482950 DOI: 10.7812/TPP/19.203] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tristano AG. Acquired amegakaryocytic thrombocytopenic purpura: Review of a not very well-defined disorder. European Journal of Internal Medicine 2005;16:477-81. [DOI: 10.1016/j.ejim.2005.04.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
7 Hitchcock IS, Kaushansky K. Thrombopoietin from beginning to end. Br J Haematol 2014;165:259-68. [PMID: 24499199 DOI: 10.1111/bjh.12772] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 13.3] [Reference Citation Analysis]
8 Chung L, Utz PJ. Antibodies in scleroderma: direct pathogenicity and phenotypic associations. Curr Rheumatol Rep 2004;6:156-63. [PMID: 15016347 DOI: 10.1007/s11926-004-0061-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
9 de Masson A, Bouaziz JD, de Latour RP, Benhamou Y, Moluçon-Chabrot C, Bay JO, Laquerrière A, Picquenot JM, Michonneau D, Leguy-Seguin V, Rybojad M, Bonnotte B, Jardin F, Lévesque H, Bagot M, Socié G. Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore) 2013;92:69-81. [PMID: 23429351 DOI: 10.1097/MD.0b013e3182899e78] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 3.1] [Reference Citation Analysis]
10 Glaspy J. Disorders of Blood Cell Production in Clinical Oncology. Abeloff's Clinical Oncology. Elsevier; 2008. pp. 677-92. [DOI: 10.1016/b978-0-443-06694-8.50049-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Mulroy E, Gleeson S, Chiruka S. Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura. Case Rep Hematol 2015;2015:171253. [PMID: 25945269 DOI: 10.1155/2015/171253] [Reference Citation Analysis]
12 Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine. Intern Med. 2019;58:3473-3478. [PMID: 31391399 DOI: 10.2169/internalmedicine.2929-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Fabien N, Monier JC. [Antireceptor and antichannel autoantibodies]. Pathol Biol (Paris) 2006;54:309-16. [PMID: 16848005 DOI: 10.1016/j.patbio.2005.12.003] [Reference Citation Analysis]
14 Ichimata S, Kobayashi M, Honda K, Shibata S, Matsumoto A, Kanno H. Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. World J Gastroenterol 2017; 23(35): 6540-6545 [PMID: 29085203 DOI: 10.3748/wjg.v23.i35.6540] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Go RS. Idiopathic cyclic thrombocytopenia. Blood Reviews 2005;19:53-9. [DOI: 10.1016/j.blre.2004.05.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nishino S, Kodaka T, Sawada Y, Goka T, Gotoh Y, Tsunemine H, Takahashi T. Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia. J Clin Exp Hematop 2018;58:166-70. [PMID: 30416171 DOI: 10.3960/jslrt.18016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]